Espin (protein)
Espin is a protein that in humans is encoded by the ESPIN gene. Espin is an actin-bundling protein that plays a crucial role in the organization of actin filaments in cells, particularly in the stereocilia of the inner ear and hair cells. Mutations in the ESPIN gene can lead to deafness due to the disruption of the stereocilia's structure and function.
Structure[edit]
Espin is a multifunctional actin-bundling protein that contains multiple actin-binding sites and Whirlin-binding sites. The protein is composed of an ankyrin repeat domain, a proline-rich domain, and a carboxy terminus that is responsible for actin-bundling activity. The ankyrin repeat domain is involved in protein-protein interactions, while the proline-rich domain is thought to interact with SH3 domain-containing proteins.
Function[edit]
Espin is involved in the elongation and maintenance of the stereocilia in the inner ear and hair cells. It bundles actin filaments, which are essential for the structure and function of the stereocilia. The protein also interacts with Whirlin, a scaffolding protein, to regulate the length and width of the stereocilia. In addition, Espin is involved in the formation of microvilli in intestinal epithelial cells.
Clinical significance[edit]
Mutations in the ESPIN gene can cause autosomal recessive non-syndromic hearing loss. These mutations disrupt the structure and function of the stereocilia, leading to deafness. Some mutations can also cause auditory neuropathy, a condition characterized by a disruption in the transmission of sound signals from the inner ear to the brain.
See also[edit]
- Actin
- Stereocilia
- Deafness
- Ankyrin repeat
- Proline
- SH3 domain
- Whirlin
- Microvilli
- Intestinal epithelial cell
- Autosomal recessive
- Auditory neuropathy
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian